Sector Charles River Laboratories International, Inc. CBOE

Aandelen

CRL

US1598641074

Biotechnologie & Medisch Onderzoek

Beurs gesloten - 21:59:50 21-08-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
295,33 USD +1,32% Intraday-grafiek van Charles River Laboratories International, Inc. +5,47% +47,92%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
+1,09%+5,26%+5,00%+19,93%+10,12%+4,44%+26,03%-22,34%+218,39% 51,61 mld.
-1,07%+2,82%+14,28%+36,25%+162,98%+474,18%+601,24%+723,35% - 44,89 mld.
+1,47%+9,79%+28,87%+54,64%+15,27%+40,15%+21,21%+2,01%+246,20% 42,77 mld.
+1,44%+7,77%+17,50%+20,95%+23,26%+19,27%+90,94%+50,03%+1.165,10% 42,58 mld.
-0,93%-4,33%+12,06%+6,50%+11,56%+17,87%+51,96%-12,07%+140,26% 31,82 mld.
+1,32%+7,30%+16,75%+44,33%+10,52%+36,93%+152,36%+248,03%+2.075,78% 17,33 mld.
-0,60%+1,93%-0,75%+2,34% - - - - - 16,63 mld.
+0,03%+3,41%+4,57%+16,36%+16,73%+7,12%+35,49%-39,06%+97,53% 14,76 mld.
+1,28%+5,41%+34,54%+85,82%+47,98%+91,01%+46,93%-30,50%+257,11% 14,09 mld.
-1,17%+5,57%+3,37%+47,75%-5,48%-1,97%-30,78%-30,50%+127,70% 13,29 mld.
-5,74%-2,32%+21,90%+79,84%+68,77%+59,88%+75,17%-39,32% - 12,06 mld.
+9,06%+39,52%+48,41%+56,36%+23,10%-5,24% - - - 13,12 mld.
+0,06%-0,11%+0,96%+52,67%+22,97%+33,93%-8,08%-39,66%+169,98% 11,34 mld.
+1,60%-0,88%-13,36%-3,14%-15,45%+63,14%+498,12%+267,51%+2.370,87% 11,12 mld.
+3,12%+2,49%+18,27%+7,24%+27,55%+710,56%+1.628,46%+33,60% - 10,49 mld.
0,00%+0,15%+0,41%+63,47%+78,52%+270,70%+454,53% - - 10,16 mld.
-1,40%+2,05%+5,67%+48,62%+53,96%+181,29%+489,28%+123,17% - 9,96 mld.
+1,67%+4,37%+11,89%-21,17%-24,48%+38,18%+52,40%+52,17%+78,92% 9,93 mld.
+2,41%-0,50%+11,58%+51,28%+76,69%+175,37%+690,17%+213,53%+1.207,80% 9,99 mld.
Gemiddelde +0,72%+4,66%+12,73%+35,26%+33,59%+123,16%+286,79%+93,75%+679,64% 20,42 mld.
Gewogen gemiddelde per kap. +0,63%+4,96%+13,89%+32,88%+38,38%+114,49%+219,25%+121,60%+590,25%
  1. Beurs
  2. Aandelen
  3. Koers CRL
  4. Koers CRL
  5. Sector Charles River Laboratories International, Inc.